Bonum Therapeutics

Seattle, WA · Founded 2021 · Privately Held (backing)

Developer of antibody-based therapeutics designed to enable targeted and regulated treatment of diseases. Bonum Therapeutics is based in Seattle, WA and was founded in 2021. Its last reported valuation was $130 million in Nov 2022. It has raised $127 million across 3 recorded rounds; the latest was a $26.9 million early-stage round in Apr 2026.

Last reported valuation
$130.0M
Oct 2026
Priced at
—
Total raised
$127.5M
Last round
Early Stage VC
Apr 2026
How much has Bonum Therapeutics raised?
$127.5Macross 3 recorded rounds · Dec 2021 – Apr 2026

Most recently, Bonum Therapeutics raised $26.9M in its Early Stage VC (Apr 2026).

Free account
More of Bonum Therapeutics with a free account
  • ·Watch Bonum Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Bonum Therapeutics round by round

3 rounds
Apr 2026Early Stage VC$26.9MSEC filing▮
8 investors participated
Nov 2022Early Stage VC$45.0MSEC filing▮
10 investors participated
Dec 2021Seed Round$1.2MSEC filing▮
5 investors participated

How much has Bonum Therapeutics raised?

Bonum Therapeutics has raised $127 million across 3 recorded rounds since 2021. The largest was a $45 million early-stage round in Nov 2022; the most recent was a $26.9 million early-stage round in Apr 2026.

Bonum Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in Apr 2026 ($26.9 million sold to 8 investors).

Bonum Therapeutics investors

6 investors are on record for Bonum Therapeutics, including Digitalis Ventures, Vivo Capital, American Century Investments and Codon Capital. The early-stage round in Apr 2026 drew 8 investors.

For fundraisers
Raising for a company like Bonum Therapeutics?

6 investors have backed Bonum Therapeutics.

See all 6 investors →

Frequently asked about Bonum Therapeutics

How much has Bonum Therapeutics raised?
Bonum Therapeutics has raised $127.5M in total across 3 recorded funding rounds.
When was Bonum Therapeutics's last funding round?
Bonum Therapeutics's most recent recorded round was Early Stage VC in Apr 2026, raising $26.9M.